Purchase this report

Mucopolysaccharidosis III Market Insights, Epidemiology and Market Forecast- 2028

Published	Pages	Publisher	Report code
Apr 2019	120	DelveInsight	ASDR-485185

Published: Apr 2019 - Pages : 120 - Publisher : DelveInsight - Report code : ASDR-485185

Mucopolysaccharidosis Treatment Market Report: Trends, Forecast and Competitive Analysis to 2031 Published: February, 2025 - Pages: 150
Mucopolysaccharidosis II (MPS II) (Hunter Syndrome) - Drugs in Development, 2021 Published: November, 2021 - Pages: 88
Mucopolysaccharidosis I (MPS I) (Hurler Syndrome) - Drugs in Development, 2021 Published: November, 2021 - Pages: 110
Mucopolysaccharidosis VI (MPS VI) (Maroteaux-Lamy Syndrome ) (Genetic Disorders) - Drugs in Development, 2021 Published: April, 2021 - Pages: 35
Mucopolysaccharidosis III (MPS III) (Sanfilippo Syndrome ) - Pipeline Review, H1 2020 Published: June, 2020 - Pages: 98
Mucopolysaccharidosis II (MPS II) (Hunter Syndrome ) - Pipeline Review, H1 2020 Published: June, 2020 - Pages: 71
Mucopolysaccharidosis I (MPS I) (Hurler Syndrome ) - Pipeline Review, H1 2020 Published: June, 2020 - Pages: 110
Mucopolysaccharidosis III (MPS III) (Sanfilippo Syndrome) - Drugs in Development, 2021 Published: November, 2021 - Pages: 115
Mucopolysaccharidosis I (MPS I) (Hurler Syndrome) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Ke... Published: November, 2022 - Pages: 73
Mucopolysaccharidosis II (MPS II) (Hunter Syndrome) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and ... Published: November, 2022 - Pages: 68